Dow Up 0.11% Nasdaq Up 0.50%

Omeros Corporation (OMER)

-NasdaqGM
14.91 Up 0.72(5.07%) Aug 29, 4:00PM EDT
|After Hours : 14.91 Up 0.00 (0.01%) Aug 29, 4:45PM EDT
Prev Close:14.19
Open:14.19
Bid:13.64 x 800
Ask:15.20 x 1200
1y Target Est:32.80
Beta:1.27
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:13.95 - 14.99
52wk Range:4.99 - 18.80
Volume:363,443
Avg Vol (3m):398,249
Market Cap:506.87M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OMERUp 5.07%506.87M
ACADUp 1.57%2.38B
ALKSUp 0.56%6.52B
HRTXUp 1.08%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):945.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.19
Quarterly EPS Est (Sep-14) :-0.64
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes products targeting inflammation, coagulopathies, and disorders of the central nervous system. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback